Cumberland Pharmaceuticals Inc. (CPIX): Price and Financial Metrics
Cumberland Pharmaceuticals Inc. (CPIX)
Today's Latest Price: $2.99 USD
Updated Oct 29 12:20pm
Add CPIX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
CPIX Stock Summary
- CPIX has a higher market value than merely 14.78% of US stocks; more precisely, its current market capitalization is $44,658,938.
- In terms of volatility of its share price, CPIX is more volatile than merely 24.42% of stocks we're observing.
- Cumberland Pharmaceuticals Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 14.64%, greater than the shareholder yield of 84.83% of stocks in our set.
- Stocks that are quantitatively similar to CPIX, based on their financial statements, market capitalization, and price volatility, are MMSI, INTT, TACT, PLPC, and NSSC.
- Visit CPIX's SEC page to see the company's official filings. To visit the company's web site, go to www.cumberlandpharma.com.
CPIX Stock Price Chart Interactive Chart >
CPIX Price/Volume Stats
| Current price | $2.99 | 52-week high | $5.80 |
| Prev. close | $2.95 | 52-week low | $2.89 |
| Day low | $2.98 | Volume | 2,690 |
| Day high | $3.01 | Avg. volume | 27,204 |
| 50-day MA | $3.20 | Dividend yield | N/A |
| 200-day MA | $3.66 | Market Cap | 45.27M |
Cumberland Pharmaceuticals Inc. (CPIX) Company Bio
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for the hospital acute care and gastroenterology markets in the United States and internationally. The company was founded in 1999 and is based in Nashville, Tennessee.
CPIX Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $2.99 | $1.43 | -52% |
Below please find a table outlining a discounted cash flow forecast for CPIX, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Cumberland Pharmaceuticals Inc ranked in the 29th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Cumberland Pharmaceuticals Inc ended up being:
- Cumberland Pharmaceuticals Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -18.66. This coverage rate is greater than that of just 6.13% of stocks we're observing for the purpose of forecasting via discounted cash flows.
- As a business, Cumberland Pharmaceuticals Inc experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than only 0% of stocks generating free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -53% |
| 1% | -52% |
| 2% | -52% |
| 3% | -51% |
| 4% | -51% |
| 5% | -50% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CPIX, try ILMN, JNJ, LMAT, ZTS, and HAPP.
Loading social stream, please wait...